Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
Biotech and Baby Food
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Warnings about one societal danger or another often portray children as the likeliest or…
Op-Eds
The EU’s Anti-Biotech Protectionist Weapon (Letter to the Editor)
America’s challenge to EU policies toward agricultural and food biotechnology is far more complex and subtle than is conveyed by U.S. Trade Representative Robert…
Study
Rethinking the Regulation of Bioengineered Crops
Full Document Available in PDF U.S. State Department conference, Agricultural Biotechnology and Developing Countries, May 21,…
Op-Eds
Mad-Cow Madness: What We Now Know about Mad-Cow Disease Shows the Folly of Excessive Precaution
When Oprah Winfrey stated on her show in 1996 that she'd never eat another hamburger, she was reacting to the remarks of Humane Society…
Op-Eds
Supporting a Risky Water Policy
As <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />U.S. environmentalists push policies to phase out use of chlorine gas at water-treatment plants, humanitarians…
Study
Spam, That Ill O’ The ISP
Full Document Available in PDF Most public attention has been focused on…